News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Release: VICTRELIS® (boceprevir) Awarded 2012 Prix Galien USA Best Pharmaceutical Agent


10/17/2012 9:57:18 AM

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that VICTRELIS® (boceprevir) 200 mg Capsules, the company’s oral treatment for chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin has received the Prix Galien USA Award for Best Pharmaceutical Agent.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES